欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4283/001
药品名称Efavirenz/ Emtricitabine/ Tenofovir disoproxil Glenmark 600 mg/200 mg/245 mg filmomhulde tabletten
活性成分
    • Efavirenz 600.0 mg
    • Emtricitabine 200.0 mg
    • Tenofovir disoproxil fumarate 245.0 mg
剂型Film-coated tablet
上市许可持有人Glenmark Arzneimittel GmbH Industriestraße 31 Grobenzell 82194 Germany
参考成员国 - 产品名称Netherlands (NL)
RVG 122988
互认成员国 - 产品名称
    • Germany (DE)
      Efavirenz/Emtricitabin/Tenofovir disoproxil Glenmark 600 mg/200 mg/245 mg Filmtabletten
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
    • Sweden (SE)
许可日期2019/04/17
最近更新日期2025/03/04
药物ATC编码
    • J05AR06 emtricitabine, tenofovir disoproxil and efavirenz
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase